Search results
GSK’s (GSK) “Buy” Rating Reiterated at Shore Capital
ETF DAILY NEWS· 22 hours agoShore Capital reissued their buy rating on shares of GSK (LON:GSK – Free Report) in a report published on Wednesday morning, Marketbeat reports. GSK has been the topic of several other reports ...
GSK's RSV Vaccine Arexvy Gets FDA Nod for Adults 50-59 Years
Zacks· 4 days agoFree Report) announced that the FDA has approved the expanded use of its respiratory syncytial virus (RSV) vaccine, Arexvy for adults aged 50-59 who are at increased risk of RSV disease. Arexvy ...
Moderna’s combo COVID and flu vaccine works better than stand-alone shots on the market, study finds
Market Watch· 4 days agoexperimental combination COVID and flu vaccine triggered better immune responses than stand-alone...
Indonesia ramps up fight against tuberculosis amid concerns on economic impact
Reuters· 4 days agoIndonesia plans to run clinical trials of several vaccines to fight surging cases of tuberculosis...
The U.S. is fighting high drug prices. Big Pharma isn't sweating — yet
Quartz· 4 days agoA key goal of the Biden administration has been to rein in healthcare costs. As the administration...
U.S. Open at Pinehurst draws companies, eco-devo officials looking to harvest deals, dollars -...
The Business Journals· 7 days agoWhen the United States Golf Association announced a few years ago that the Pinehurst No. 2 course in...
FTC Warns Pharma Companies It Means Business with Its Orange Book Listing Policy | JD Supra
JD Supra· 2 days agoPolicy differences are endemic in politics, and the phrase "causing more heat than light" regarding federal drug policy comes readily to mind listening to the rhetoric coming from the Federal ...